Submission Details
| 510(k) Number | K841114 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 15, 1984 |
| Decision Date | June 14, 1984 |
| Days to Decision | 91 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | — |
K841114 is an FDA 510(k) clearance for the ALLO-TYPE HUMAN IMMUNOGLOBULIN-, a Ng1m(a), Antigen, Antiserum, Control (Class I — General Controls, product code DGX), submitted by Genetic Testing Institute (Mchenry, US). The FDA issued a Cleared decision on June 14, 1984, 91 days after receiving the submission on March 15, 1984. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5065.
| 510(k) Number | K841114 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 15, 1984 |
| Decision Date | June 14, 1984 |
| Days to Decision | 91 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | — |
| Product Code | DGX — Ng1m(a), Antigen, Antiserum, Control |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 866.5065 |